These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23507693)

  • 1. Clinical outcomes following the use of ovine forestomach matrix (endoform dermal template) to treat chronic wounds.
    Liden BA; May BC
    Adv Skin Wound Care; 2013 Apr; 26(4):164-7. PubMed ID: 23507693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Multicenter Evaluation of an Advanced Extracellular Matrix for Wound Management.
    Raizman R; Hill R; Woo K
    Adv Skin Wound Care; 2020 Aug; 33(8):437-444. PubMed ID: 32472774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ulcerated necrobiosis lipoidica with ovine forestomach matrix.
    Simcock JW; Than M; Ward BR; May BC
    J Wound Care; 2013 Jul; 22(7):383-4. PubMed ID: 24159661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds.
    Winters CL; Brigido SA; Liden BA; Simmons M; Hartman JF; Wright ML
    Adv Skin Wound Care; 2008 Aug; 21(8):375-81. PubMed ID: 18679086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovine forestomach matrix biomaterial is a broad spectrum inhibitor of matrix metalloproteinases and neutrophil elastase.
    Negron L; Lun S; May BC
    Int Wound J; 2014 Aug; 11(4):392-7. PubMed ID: 23116239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regenerative materials that facilitate wound healing.
    Mulder G; Wallin K; Tenenhaus M
    Clin Plast Surg; 2012 Jul; 39(3):249-67. PubMed ID: 22732374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-of-the-art wound healing: skin substitutes for chronic wounds.
    Han G
    Cutis; 2014 Jan; 93(1):E13-6. PubMed ID: 24505591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of an Esterified Hyaluronic Acid Matrix in the Treatment of Chronic Lower Extremity Wounds: A Case Series.
    Cheung T; Laidley Z; Jones J; Wu S
    Wounds; 2018 Dec; 30(12):367-371. PubMed ID: 30507547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active wound coverings: bioengineered skin and dermal substitutes.
    Límová M
    Surg Clin North Am; 2010 Dec; 90(6):1237-55. PubMed ID: 21074039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wound bed preparation 2014 update: management of critical colonization with a gentian violet and methylene blue absorbent antibacterial dressing and elevated levels of matrix metalloproteases with an ovine collagen extracellular matrix dressing.
    Sibbald RG; Ovington LG; Ayello EA; Goodman L; Elliott JA
    Adv Skin Wound Care; 2014 Mar; 27(3 Suppl 1):1-6. PubMed ID: 24521847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue engineering.
    Sefton MV; Woodhouse KA
    J Cutan Med Surg; 1998 Dec; 3 Suppl 1():S1-18-23. PubMed ID: 10082603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial.
    Mostow EN; Haraway GD; Dalsing M; Hodde JP; King D;
    J Vasc Surg; 2005 May; 41(5):837-43. PubMed ID: 15886669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the wound healing properties of Algisite M dressings.
    Kammerlander G; Eberlein T
    Nurs Times; 2003 Oct 21-27; 99(42):54-6. PubMed ID: 14618992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel.
    de Leon JM; Driver VR; Fylling CP; Carter MJ; Anderson C; Wilson J; Dougherty RM; Fuston D; Trigilia D; Valenski V; Rappl LM
    Adv Skin Wound Care; 2011 Aug; 24(8):357-68. PubMed ID: 21768787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix prevents split-skin grafting in selected cases.
    Barendse-Hofmann MG; van Doorn LP; Oskam J; Steenvoorde P
    J Wound Care; 2007 Nov; 16(10):455-8. PubMed ID: 18065022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-interventional study to investigate the efficacy and safety of Tegaderm™ Matrix in the treatment of patients with therapy-refractory chronic wounds.
    Weindorf M; Körber A; Klode J; Dissemond J
    J Dtsch Dermatol Ges; 2012 Jun; 10(6):412-20. PubMed ID: 21999577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leg ulcer treatment outcomes with new ovine collagen extracellular matrix dressing: a retrospective case series.
    Bohn GA; Gass K
    Adv Skin Wound Care; 2014 Oct; 27(10):448-54. PubMed ID: 25198432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of a Novel Autologous Wound Matrix in the Management of Complicated, Chronic Wounds: A Pilot Study.
    Kushnir I; Kushnir A; Serena TE; Garfinkel D
    Wounds; 2016 Sep; 28(9):317-327. PubMed ID: 27701127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional extracellular matrix biomaterial derived from ovine forestomach.
    Lun S; Irvine SM; Johnson KD; Fisher NJ; Floden EW; Negron L; Dempsey SG; McLaughlin RJ; Vasudevamurthy M; Ward BR; May BC
    Biomaterials; 2010 Jun; 31(16):4517-29. PubMed ID: 20226520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compromised wound healing: a scientific approach to treatment.
    Moore K
    Br J Community Nurs; 2003 Jun; 8(6):274-8. PubMed ID: 12819586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.